APA (7th ed.) Citation

Ragusi, M. A., Bismeijer, T., Velden, B. H. v. d., Loo, C. E., Canisius, S., Wesseling, J., . . . Gilhuijs, K. G. (2021). Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients. Elsevier.

Chicago Style (17th ed.) Citation

Ragusi, Max A.A., Tycho Bismeijer, Bas H.M. van der Velden, Claudette E. Loo, Sander Canisius, Jelle Wesseling, Lodewyk F.A Wessels, Sjoerd G. Elias, and Kenneth G.A Gilhuijs. Contralateral Parenchymal Enhancement on MRI Is Associated with Tumor Proteasome Pathway Gene Expression and Overall Survival of Early ER+/HER2-breast Cancer Patients. Elsevier, 2021.

MLA (8th ed.) Citation

Ragusi, Max A.A., et al. Contralateral Parenchymal Enhancement on MRI Is Associated with Tumor Proteasome Pathway Gene Expression and Overall Survival of Early ER+/HER2-breast Cancer Patients. Elsevier, 2021.